Quorum Health Corporation (NYSE:QHC)‘s stock had its “hold” rating reaffirmed by research analysts at Royal Bank Of Canada in a research note issued to investors on Tuesday. They presently have a $5.00 price objective on the stock. Royal Bank Of Canada’s price objective would indicate a potential downside of 7.06% from the stock’s current price.

Other analysts have also issued research reports about the company. Zacks Investment Research lowered Quorum Health Corporation from a “buy” rating to a “hold” rating in a report on Wednesday, August 9th. Credit Suisse Group raised their target price on Quorum Health Corporation from $3.00 to $4.00 and gave the company a “neutral” rating in a research note on Monday, August 14th. Morgan Stanley assumed coverage on Quorum Health Corporation in a report on Tuesday, June 6th. They set an “underweight” rating and a $3.00 target price on the stock. Deutsche Bank AG lifted their target price on Quorum Health Corporation from $3.00 to $3.50 and gave the stock a “hold” rating in a report on Monday, August 14th. Finally, ValuEngine upgraded shares of Quorum Health Corporation from a “strong sell” rating to a “sell” rating in a research report on Friday, September 1st. Three analysts have rated the stock with a sell rating, three have assigned a hold rating and one has given a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $4.13.

Shares of Quorum Health Corporation (NYSE QHC) opened at 5.38 on Tuesday. Quorum Health Corporation has a one year low of $3.75 and a one year high of $9.46. The firm has a 50 day moving average of $4.70 and a 200 day moving average of $4.70. The stock’s market cap is $163.00 million.

Quorum Health Corporation (NYSE:QHC) last issued its quarterly earnings results on Wednesday, August 9th. The company reported ($0.42) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.66) by $0.24. Quorum Health Corporation had a negative return on equity of 26.69% and a negative net margin of 6.88%. The firm had revenue of $530.15 million during the quarter, compared to analyst estimates of $513.50 million. During the same period last year, the company posted ($0.82) EPS. The firm’s quarterly revenue was up .1% on a year-over-year basis. On average, equities research analysts predict that Quorum Health Corporation will post ($1.52) EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “Quorum Health Corporation (QHC) Rating Reiterated by Royal Bank Of Canada” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another publication, it was illegally stolen and republished in violation of US & international trademark and copyright law. The legal version of this story can be read at https://www.thecerbatgem.com/2017/10/03/quorum-health-corporation-qhc-rating-reiterated-by-royal-bank-of-canada.html.

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Davidson Kempner Capital Management LP increased its holdings in shares of Quorum Health Corporation by 7.2% in the second quarter. Davidson Kempner Capital Management LP now owns 2,971,526 shares of the company’s stock valued at $12,332,000 after buying an additional 200,000 shares in the last quarter. Goldman Sachs Group Inc. lifted its position in shares of Quorum Health Corporation by 176.7% during the 2nd quarter. Goldman Sachs Group Inc. now owns 2,377,832 shares of the company’s stock valued at $9,868,000 after acquiring an additional 1,518,355 shares during the last quarter. JPMorgan Chase & Co. boosted its stake in shares of Quorum Health Corporation by 81.4% during the 1st quarter. JPMorgan Chase & Co. now owns 1,707,292 shares of the company’s stock worth $9,288,000 after acquiring an additional 766,051 shares in the last quarter. Kohlberg Kravis Roberts & Co. L.P. boosted its stake in shares of Quorum Health Corporation by 502.3% during the 1st quarter. Kohlberg Kravis Roberts & Co. L.P. now owns 1,663,181 shares of the company’s stock worth $9,048,000 after acquiring an additional 1,387,064 shares in the last quarter. Finally, Vanguard Group Inc. boosted its stake in shares of Quorum Health Corporation by 10.3% during the 1st quarter. Vanguard Group Inc. now owns 1,568,666 shares of the company’s stock worth $8,534,000 after acquiring an additional 145,904 shares in the last quarter. 81.42% of the stock is currently owned by institutional investors.

About Quorum Health Corporation

Quorum Health Corporation is an operator and manager of general acute care hospitals and outpatient services in the United States. The Company operates in two segments: Hospital operations, which includes its general acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services, and hospital management advisory and consulting services, which includes Quorum Health Resources, LLC (QHR).

Receive News & Stock Ratings for Quorum Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quorum Health Corporation and related stocks with our FREE daily email newsletter.